Inventiva (IVA) IPO Opens Modestly Higher

Today's IPO for Inventiva (NASDAQ: IVA) opened for trading at $15.13 after pricing at $14.40.

Jefferies LLC, Stifel, Nicolaus & Company, Incorporated and Guggenheim Securities, LLC are acting as Joint Global Coordinators and bookrunners for the Offering. H.C. Wainwright & Co., LLC is acting as lead manager and Roth Capital Partners, LLC and KBC Securities USA LLC are acting as co-managers for the Offering.

Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of NASH, MPS and other diseases with significant unmet medical need.

You May Also Be Interested In

• Snow Rothschild Acquisition Corp. closes $200 million IPO
• Parabilis Medicines (PBLS) Opens at $33.35, IPO priced at $20, Trading $28.31
• SpaceX IPO over four times oversubscribed - Bloomberg